{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:41:35Z","timestamp":1792082495367,"version":"4.4.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1097\/wnf.0b013e31803d357f","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T06:44:22Z","timestamp":1613025862000},"page":"206-212","source":"Crossref","is-referenced-by-count":38,"title":["An Open-Label Trial of Escitalopram in the Treatment of Pathological Gambling"],"prefix":"10.1097","volume":"30","author":[{"given":"Donald W.","family":"Black","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsie T.","family":"Forbush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-4-20210203","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/scnp.2001.22919","article-title":"The epidemiology of pathological gambling.","volume":"6","author":"Cunningham-Williams","year":"2001","journal-title":"Semin Clin Neuropsychiatry"},{"key":"R3-4-20210203","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1176\/ps.49.11.1434","article-title":"Clinical features and psychiatric comorbidity in 30 subjects reporting pathological gambling behavior.","volume":"49","author":"Black","year":"1998","journal-title":"Psychiatr Serv"},{"key":"R4-4-20210203","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/00005053-200207000-00007","article-title":"Suicide ideation and attempts in treatment-seeking pathological gamblers.","volume":"190","author":"Petry","year":"2002","journal-title":"J Nerv Ment Dis"},{"key":"R5-4-20210203","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1023\/A:1023005115932","article-title":"Gambling and the health of the public.","volume":"15","author":"Korn","year":"1999","journal-title":"J Gambl Stud"},{"key":"R6-4-20210203","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3928\/0048-5713-20020301-09","article-title":"Psychosocial treatments for pathological gamblers.","volume":"36","author":"Petry","year":"2002","journal-title":"Psychiatr Ann"},{"key":"R8-4-20210203","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0006-3223(01)01079-4","article-title":"Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling.","volume":"49","author":"Kim","year":"2001","journal-title":"Biol Psychiatry"},{"key":"R9-4-20210203","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/appi.ajp.163.2.303","article-title":"Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.","volume":"163","author":"Grant","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R10-4-20210203","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4088\/JCP.v63n0606","article-title":"A double-blind placebo controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling.","volume":"63","author":"Kim","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R11-4-20210203","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.yic.0000073881.93678.21","article-title":"Paroxetine treatment of pathological gambling: a multi-center randomized controlled trial.","volume":"18","author":"Grant","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"key":"R12-4-20210203","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.jcp.0000114844.58996.4a","article-title":"An open-label trial of bupropion in the treatment of pathological gambling.","volume":"24","author":"Black","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"R13-4-20210203","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.4088\/JCP.v63n1114","article-title":"Nefazodone treatment of pathological gambling: a prospective open-label controlled trial.","volume":"63","author":"Pallanti","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R14-4-20210203","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4088\/JCP.v63n0109","article-title":"An open-label study of citalopram in the treatment of pathological gambling.","volume":"63","author":"Zimmerman","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R15-4-20210203","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0006-3223(01)01145-3","article-title":"Second generation SSRIs: human monoamine transporter binding profile of S-citalopram and R-fluoxetine.","volume":"50","author":"Owens","year":"2001","journal-title":"Biol Psychiatry"},{"key":"R17-4-20210203","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1176\/ajp.144.9.1184","article-title":"The South Oaks Gambling Screen (SOGS): a new instrument for identification of pathological gamblers.","volume":"144","author":"Lesieur","year":"1987","journal-title":"Am J Psychiatry"},{"key":"R20-4-20210203","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness.","volume":"6","author":"Hamilton","year":"1967","journal-title":"Br J Soc Clin Psychol"},{"key":"R23-4-20210203","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archpsyc.1976.01770060086012","article-title":"The Global Assessment Scale. A procedure for measuring overall severity of psychiatric disturbance.","volume":"33","author":"Endicott","year":"1976","journal-title":"Arch Gen Psychiatry"},{"key":"R27-4-20210203","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00004850-200607000-00002","article-title":"Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label study with double-blind discontinuation.","volume":"21","author":"Grant","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"R28-4-20210203","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1360-0443.1991.tb01782.x","article-title":"Control versus abstinence in the treatment of pathological gambling: a two to nine year follow up.","volume":"86","author":"Blaszczynski","year":"1991","journal-title":"Br J Addict"},{"key":"R29-4-20210203","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10899-004-1932-8","article-title":"Pharmacologic treatment of pathological gambling.","volume":"21","author":"Hollander","year":"2005","journal-title":"J Gambl Stud"},{"key":"R30-4-20210203","first-page":"44","article-title":"A pilot placebo-controlled study of fluvoxamine for pathological gambling.","volume":"63","author":"Blanco","year":"2002","journal-title":"Ann Clin Psychiatry"},{"key":"R31-4-20210203","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0006-3223(00)00241-9","article-title":"A randomized double-blind fluvoxamine\/placebo crossover trial in pathological gambling.","volume":"47","author":"Hollander","year":"2000","journal-title":"Biol Psychiatry"},{"key":"R32-4-20210203","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4088\/JCP.v66n0104","article-title":"Sertraline treatment in pathological gambling.","volume":"66","author":"Saiz-Ruiz","year":"2005","journal-title":"J Clin Psychiatry"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002826-200707000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T06:44:36Z","timestamp":1613025876000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-200707000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e31803d357f","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}